Researchers are excited about this new drug, a novel dual treatment showing significant data in initial trials for body reduction . It functions by impacting both systems: GLP-1 and GIP, which , when stimulated, assist regulate appetite and improve metabolism . Initial observations suggest substantial size loss and likely benefits for individuals d